person · Reporting owner

BARON RICHARD A

Disclosed activity across 1 company

Tapewire entity: 112436
SEC CIK: 0001287754

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Immunome Inc.IMNM · Entity 4219	Director	June 08, 2023	June 12, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Immunome Inc.

Report date June 08, 2023 · Filed June 12, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.84 · Expires 2033-06-08	Direct	6,500	Reported balance After 2023-06-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2023-06-08 · Grant · Acquired 6,500 · Balance 6,500 F1: The shares subject to the options shall vest 25% every quarter after the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to the options shall vest 25% every quarter after the grant date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 08, 2023 Filed Jun 12, 2023 20:52 UTC	Immunome Inc. IMNM · Entity 4219	GrantStock Option (Right to Buy) · Derivative	6,500	$0.00 Strike: $4.84	$0.00	Disclosure SEC source: 0001104659-23-070399 · tm2318426-5_4seq1.xml · derivative · entry 1 BARON RICHARD A · CIK 0001287754 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2033-06-08 F1 · derivative.exercise_date: The shares subject to the options shall vest 25% every quarter after the grant date. Read SEC document
June 16, 2022 Filed Jun 21, 2022 22:01 UTC	Immunome Inc. IMNM · Entity 4219	GrantStock Option (Right to Buy) · Derivative	6,500	$0.00 Strike: $2.62	$0.00	Disclosure SEC source: 0001104659-22-073093 · tm2218674-1_4seq1.xml · derivative · entry 1 BARON RICHARD A · CIK 0001287754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2032-06-16 F1 · derivative.exercise_date: The shares subject to the options shall vest 25% every quarter after the grant date. Read SEC document
August 18, 2021 Filed Aug 20, 2021 22:25 UTC	Immunome Inc. IMNM · Entity 4219	Exercise / conversionStock Option (Right to Buy) · Derivative	2,343	$0.00 Strike: $11.38	$0.00	Disclosure SEC source: 0001104659-21-108267 · tm2125608-1_4seq1.xml · derivative · entry 2 BARON RICHARD A · CIK 0001287754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,157 Underlying: Common Stock · 2,343 shares Expires 2030-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vest/vested one-twelfth (1/12th) on February 3, 2021, and one-twelfth (1/12th) every three months thereafter. Read SEC document
August 18, 2021 Filed Aug 20, 2021 22:25 UTC	Immunome Inc. IMNM · Entity 4219	Exercise / conversionCommon Stock	2,343	$11.38	$26,663.34	Disclosure SEC source: 0001104659-21-108267 · tm2125608-1_4seq1.xml · nonDerivative · entry 1 BARON RICHARD A · CIK 0001287754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 28, 2021 Filed Jun 2, 2021 00:01 UTC	Immunome Inc. IMNM · Entity 4219	GrantStock Option (Right to Buy) · Derivative	3,750	$0.00 Strike: $20.92	$0.00	Disclosure SEC source: 0001104659-21-075259 · tm2118079-1_4seq1.xml · derivative · entry 1 BARON RICHARD A · CIK 0001287754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2031-05-28 F1 · derivative.exercise_date: The shares subject to the option shall vest 25% every quarter after the grant date. Read SEC document
November 03, 2020 Filed Nov 6, 2020 01:10 UTC	Immunome Inc. IMNM · Entity 4219	GrantStock Option (Right to Buy) · Derivative	7,500	$0.00 Strike: $11.38	$0.00	Disclosure SEC source: 0001104659-20-122028 · a4.xml · derivative · entry 1 BARON RICHARD A · CIK 0001287754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-11-03 F1 · security: One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter. F1 · derivative.exercise_date: One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.